NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.19933.d: Isoleucine--tRNA ligase (MG_345)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: target approved
center reference id: MygeA.19933.d
is community request: True
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_81194

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.405
UniProt: P47587

Enzyme & Pathway Information

Pathway Pathway ID EC Number
tRNA charging TRNA-CHARGING-PWY 6.1.1.5

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MDLKKTLLMP KTSFAMQANL STSEKNFHDF WKDKKVFQKL KKQNKGKQIK ILHDGPPYAN GSIHVGHALN KILKDFILRS WLYEGYDVVF IPGWDCHGLP IEHAVSKKNP SSYSNLSTVE KRKLCHQFAL SQIAVQKEQF QRLGLLNDFQ NCYYTIDESF QFKELELFLQ AIKKGLIFQD LKPTYWSPIS RTSLAEAEIE YKEVNSIALY LTFKVSKSDF LDENANLLVW TTTPWTLPTN QAIAIHPDFD YLLFEYNQQK FVILEKLFEV FTNKLNWTNA IKLKKFKGSN LKNSSYSHCF YNKVLPVLMG IHVVDNEGTG IVHSSPAFGI DDFYLCQKNK IKEVLISIDE KGVFNNLLND KELENCFYLK ANDLIINRLK QNNSFIFSEV ISHREPHDWR SKTPVIYRAS KQLFIKTKSI KKQLKKQINQ VNFLNSKNQL RLKEMLLQRD EWCISRQRVW GLPIPIVYAN NKPLLDFSTI QYTIKQLKKH GIDSWFEKDV TCFLKPDKTK KWVKYHKEID TLDVWFDSGS SYNVLEINKY GSIADLYIEG SDQYRGWFNS SSNCGIIQND LIPFKSLVSH GFTLDENGNK MSKSLGNIVD PLKICDQYGA DILRLWVANT DWQIDNKIGV NILKQVAEQY RRIRNSLLRF ILGNINGFNF TSMDDYKFSL EDKIVIHKTN SLVEQIEKFL EKYNFLGCLK VINKFVLWLS SWYFEIIKDT LYCDAKNNPN RLAKQAVLNY IFTQLISFLN IFIPHTAEDA WKNYSFNKKP ISVNLFTKPT VFKVANSKNL GNIYKTFTSI KNAAFKEIEK LRKEGLISKN NQIELTVGIN KKIPKKLKDN LALWLNVNSV NLTNNENEIK VKKTKKTMCE RCWNFQTIIK QKLDHNLCSR CFKVC

NT Sequence
ATGGACTTAA AAAAGACATT GTTAATGCCT AAAACATCCT TTGCGATGCA GGCAAATTTA TCTACTAGTG AAAAGAATTT TCATGATTTT TGAAAAGATA AAAAAGTCTT TCAAAAATTA AAAAAACAGA ATAAAGGAAA ACAGATAAAA ATACTGCATG ATGGACCACC TTATGCAAAT GGTAGTATTC ATGTGGGACA TGCTCTTAAC AAGATTTTAA AAGACTTCAT TTTACGTAGT TGGTTATATG AAGGATATGA TGTTGTTTTT ATTCCTGGTT GGGATTGTCA TGGACTACCA ATAGAACATG CAGTTAGTAA GAAAAACCCT AGTAGTTATA GCAATCTTTC AACTGTTGAA AAAAGAAAAT TATGTCATCA GTTTGCACTT TCACAAATTG CAGTTCAAAA AGAACAATTT CAAAGACTGG GACTTTTAAA TGATTTTCAA AACTGTTATT ACACAATAGA TGAGAGTTTT CAATTTAAGG AACTTGAACT ATTTTTACAA GCAATTAAAA AAGGGCTCAT TTTTCAAGAT TTAAAACCAA CTTATTGATC ACCAATTTCA AGAACTTCAC TTGCTGAAGC GGAAATTGAA TATAAAGAAG TTAATTCAAT TGCACTTTAT TTAACTTTTA AAGTTTCTAA AAGTGATTTT TTAGATGAAA ATGCTAATTT ATTAGTTTGA ACAACAACTC CTTGAACACT ACCAACTAAT CAAGCAATTG CCATTCATCC TGATTTTGAT TATCTTCTTT TTGAATATAA CCAACAAAAA TTTGTTATCT TGGAAAAATT ATTTGAAGTT TTTACAAATA AGTTAAATTG AACAAATGCA ATTAAACTAA AAAAATTCAA GGGTTCAAAT TTAAAAAATT CAAGCTATTC TCATTGTTTT TATAACAAGG TTTTACCAGT TCTAATGGGA ATACATGTTG TTGATAATGA GGGAACAGGT ATTGTTCACA GCTCCCCTGC ATTTGGAATT GATGATTTTT ATCTTTGTCA AAAAAACAAG ATTAAAGAAG TTTTGATTTC TATTGATGAG AAAGGTGTAT TTAATAACTT ACTTAATGAT AAAGAACTTG AGAATTGTTT TTATCTTAAA GCAAATGATC TAATTATTAA TCGTTTAAAA CAAAACAATA GCTTTATTTT TTCTGAAGTT ATTTCCCACC GCGAACCACA TGATTGACGC TCAAAAACTC CAGTTATATA CCGTGCTTCC AAACAATTAT TCATTAAAAC TAAATCAATA AAAAAGCAGT TAAAAAAACA AATTAATCAA GTTAATTTTT TAAATTCAAA AAATCAATTG AGATTAAAAG AGATGCTTTT ACAACGTGAT GAATGATGTA TCTCACGTCA AAGAGTATGG GGCTTGCCTA TACCAATTGT TTATGCAAAT AACAAACCAT TGTTAGATTT TTCAACAATT CAATACACAA TTAAACAATT GAAAAAGCAT GGTATTGATA GTTGATTTGA AAAAGATGTA ACTTGTTTTT TAAAACCTGA TAAAACCAAA AAATGAGTTA AGTATCACAA GGAGATTGAT ACATTAGATG TTTGATTTGA CTCAGGTTCT TCCTATAATG TTTTGGAAAT AAATAAATAT GGTTCAATAG CTGATCTTTA TATTGAAGGT TCTGATCAAT ATCGGGGTTG GTTCAACTCT TCTTCAAATT GCGGAATTAT TCAAAATGAT TTAATCCCTT TTAAATCACT TGTTTCACAT GGTTTTACAC TTGATGAAAA TGGCAATAAA ATGTCAAAGT CATTAGGAAA CATAGTTGAT CCTTTAAAAA TTTGTGATCA ATATGGAGCG GATATATTAA GGTTGTGAGT TGCTAATACT GATTGACAAA TTGATAACAA AATAGGTGTT AATATTCTTA AACAAGTTGC TGAACAATAC CGCAGAATTA GAAATAGTTT ACTACGTTTT ATTTTGGGTA ATATTAATGG ATTTAACTTT ACATCAATGG ATGATTATAA GTTTTCACTA GAAGACAAAA TAGTTATCCA TAAAACTAAT TCACTAGTAG AACAAATTGA GAAATTTTTA GAGAAATATA ATTTTTTAGG TTGCCTAAAA GTGATTAATA AGTTTGTTTT ATGACTATCA AGCTGATACT TTGAAATAAT TAAAGACACC TTATATTGTG ATGCTAAAAA TAATCCTAAT CGTTTAGCTA AACAAGCTGT TTTAAACTAT ATTTTTACAC AACTAATCAG TTTTTTAAAT ATCTTTATTC CCCACACTGC AGAAGATGCT TGAAAAAACT ATTCATTCAA TAAAAAACCA ATAAGTGTGA ACCTCTTTAC AAAACCGACT GTTTTTAAAG TTGCTAACTC TAAGAATTTA GAAAATATCT ATAAAACTTT TACTAGTATT AAAAATGCTG CTTTCAAAGA AATTGAAAAG CTAAGAAAAG AAGGGTTGAT TTCTAAAAAT AATCAAATTG AATTAACCGT TGGAATTAAT AAAAAAATAC CCAAAAAATT AAAGGATAAT CTCGCACTTT GACTTAATGT AAACAGTGTT AATTTAACAA ATAATGAAAA TGAAATTAAA GTTAAAAAAA CTAAAAAAAC AATGTGTGAA AGATGCTGAA ATTTTCAAAC AATCATTAAG CAAAAATTAG ATCATAATTT GTGCTCACGT TGTTTTAAAG TGTGT

© 2020 Seattle Children's Research Institute. All rights reserved.